title: [The allergic pregnant woman].
abstract: Drugs administrated to pregnant women must be carefully monitored. Prevention of dietary sensitization in foetus via the mother is still discussed. However, it must not induce any dietary deficiency to both the mother and the foetus. Environmental prevention is also controversial. Asthmatic pregnant women must be treated because under- or non treatment is more dangerous for both the woman and the foetus compared to eventual drug side effect. Asthma must be treated with inhaled glucocorticosteroid in order to be stabilized because giving birth is the only moment which can not be interrupted. Antihistamine-H1 which can be used during pregnancy are dexchlorpheniramine for the first and second third and cetirizine during the last third of the pregnancy.
authors.affiliation: Service de médecine interne A-Pneumologie, CHU G Doumergue-5, rue Hoche-30000 Nîmes.
authors.forename: A
authors.initials: A
authors.lastname: Pâris-Köhler
authors.forename: M L
authors.initials: ML
authors.lastname: Megret-Gabeaud
authors.forename: C
authors.initials: C
authors.lastname: Fabre
authors.forename: P
authors.initials: P
authors.lastname: Mares
authors.forename: D
authors.initials: D
authors.lastname: Vincent
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000209:etiology / Q000517:prevention & control*; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D018926:Anti-Allergic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D018927:Anti-Asthmatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000627:therapeutic use; D000075202:Contraindications; D004781:Environmental Exposure; D005260:Female; D005333:Fetus / Q000187:drug effects; D005512:Food Hypersensitivity / Q000178:diet therapy; D006634:Histamine H1 Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000517:prevention & control; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D009748:Nutrition Disorders / Q000209:etiology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy / Q000276:immunology*; D011644:Puerperal Disorders / Q000517:prevention & control
chemical_list: D000305:Adrenal Cortex Hormones; D018926:Anti-Allergic Agents; D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents; D006634:Histamine H1 Antagonists